• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    3.40 Down 0.08(2.30%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:3.48
    Open:3.46
    Bid:2.68 x 100
    Ask:6.10 x 100
    1y Target Est:16.00
    Beta:1.64
    Next Earnings Date:N/A
    Day's Range:3.40 - 3.74
    52wk Range:3.00 - 18.62
    Volume:120,322
    Avg Vol (3m):304,026
    Market Cap:75.22M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GALT

    Comparison

    Symbol% ChgMkt Cap
    GALTDown 2.30%75.22M
    MNTADown 2.08%713.28M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.77
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback